English
简体中文
Total: £ 56.28
Published Date: 2025-03-24 | Pages: 86 | Tables: 85 | Pharma & Healthcare
The global market for Eptacog Alfa (rFVIIa) was valued at US$ 1315 million in the year 2024 and is projected to reach a revised size of US$ 1794 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Recombinant human coagulation factor VIIa is a drug from Novo Nordisk for bleeding episodes and prevention of bleeding during surgical procedures or invasive procedures in the following patient groups:
1. Inhibitors of coagulation factor VIII or IX 5BU in congenital hemophilia patients; 2. Congenital hemophilia patients who are expected to have a high memory response to injection of coagulation factor VIII or coagulation factor IX; 3. Acquired blood 4. Patients with congenital FVII deficiency; 5. Patients with thrombocytopenia who have GP IIb-IIIa and/or HLA antibodies and past or present ineffective or poor platelet transfusions.
Novo Nordisk is the largest manufacturers of eptacog alfa (rFVIIa) in the world, has a share about 92%. Other players include LFB SA, GENERIUM,Northland-bio, and Northland-bioi, etc. The key players are mainly located in Europe, North America, China, and Japan. In terms of product, freeze-dried preparation is the largest segment, with a share over 52%. And in terms of application, the largest application is hemophilia, with a share over 48%, followed by acquired hemophilia.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Eptacog Alfa (rFVIIa), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eptacog Alfa (rFVIIa).
The Eptacog Alfa (rFVIIa) market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Eptacog Alfa (rFVIIa) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eptacog Alfa (rFVIIa) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
LFB SA
GENERIUM
Northland-bio
CSL
Shire (Takeda)
Bayer
Segment by Type
Freeze-dried Preparation
Freeze-dried Powder
Segment by Application
Hemophilia
Acquired Hemophilia
Factor VII Deficiency
Glanzmann Thrombasthenia (GT)
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eptacog Alfa (rFVIIa) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eptacog Alfa (rFVIIa) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Eptacog Alfa (rFVIIa) Market Overview
1.1 Product Definition
1.2 Eptacog Alfa (rFVIIa) by Type
1.2.1 Global Eptacog Alfa (rFVIIa) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Freeze-dried Preparation
1.2.3 Freeze-dried Powder
1.3 Eptacog Alfa (rFVIIa) by Application
1.3.1 Global Eptacog Alfa (rFVIIa) Market Value by Application (2024 VS 2031)
1.3.2 Hemophilia
1.3.3 Acquired Hemophilia
1.3.4 Factor VII Deficiency
1.3.5 Glanzmann Thrombasthenia (GT)
1.4 Global Eptacog Alfa (rFVIIa) Market Size Estimates and Forecasts
1.4.1 Global Eptacog Alfa (rFVIIa) Revenue 2020-2031
1.4.2 Global Eptacog Alfa (rFVIIa) Sales 2020-2031
1.4.3 Global Eptacog Alfa (rFVIIa) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Eptacog Alfa (rFVIIa) Market Competition by Manufacturers
2.1 Global Eptacog Alfa (rFVIIa) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Eptacog Alfa (rFVIIa) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Eptacog Alfa (rFVIIa) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Eptacog Alfa (rFVIIa), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eptacog Alfa (rFVIIa), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eptacog Alfa (rFVIIa), Product Type & Application
2.7 Global Key Manufacturers of Eptacog Alfa (rFVIIa), Date of Enter into This Industry
2.8 Global Eptacog Alfa (rFVIIa) Market Competitive Situation and Trends
2.8.1 Global Eptacog Alfa (rFVIIa) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Eptacog Alfa (rFVIIa) Players Market Share by Revenue
2.8.3 Global Eptacog Alfa (rFVIIa) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Eptacog Alfa (rFVIIa) Market Scenario by Region
3.1 Global Eptacog Alfa (rFVIIa) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Eptacog Alfa (rFVIIa) Sales by Region: 2020-2031
3.2.1 Global Eptacog Alfa (rFVIIa) Sales by Region: 2020-2025
3.2.2 Global Eptacog Alfa (rFVIIa) Sales by Region: 2026-2031
3.3 Global Eptacog Alfa (rFVIIa) Revenue by Region: 2020-2031
3.3.1 Global Eptacog Alfa (rFVIIa) Revenue by Region: 2020-2025
3.3.2 Global Eptacog Alfa (rFVIIa) Revenue by Region: 2026-2031
3.4 North America Eptacog Alfa (rFVIIa) Market Facts & Figures by Country
3.4.1 North America Eptacog Alfa (rFVIIa) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Eptacog Alfa (rFVIIa) Sales by Country (2020-2031)
3.4.3 North America Eptacog Alfa (rFVIIa) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eptacog Alfa (rFVIIa) Market Facts & Figures by Country
3.5.1 Europe Eptacog Alfa (rFVIIa) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Eptacog Alfa (rFVIIa) Sales by Country (2020-2031)
3.5.3 Europe Eptacog Alfa (rFVIIa) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eptacog Alfa (rFVIIa) Market Facts & Figures by Region
3.6.1 Asia Pacific Eptacog Alfa (rFVIIa) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Eptacog Alfa (rFVIIa) Sales by Region (2020-2031)
3.6.3 Asia Pacific Eptacog Alfa (rFVIIa) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Eptacog Alfa (rFVIIa) Market Facts & Figures by Country
3.7.1 Latin America Eptacog Alfa (rFVIIa) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Eptacog Alfa (rFVIIa) Sales by Country (2020-2031)
3.7.3 Latin America Eptacog Alfa (rFVIIa) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eptacog Alfa (rFVIIa) Market Facts & Figures by Country
3.8.1 Middle East and Africa Eptacog Alfa (rFVIIa) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Eptacog Alfa (rFVIIa) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Eptacog Alfa (rFVIIa) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eptacog Alfa (rFVIIa) Sales by Type (2020-2031)
4.1.1 Global Eptacog Alfa (rFVIIa) Sales by Type (2020-2025)
4.1.2 Global Eptacog Alfa (rFVIIa) Sales by Type (2026-2031)
4.1.3 Global Eptacog Alfa (rFVIIa) Sales Market Share by Type (2020-2031)
4.2 Global Eptacog Alfa (rFVIIa) Revenue by Type (2020-2031)
4.2.1 Global Eptacog Alfa (rFVIIa) Revenue by Type (2020-2025)
4.2.2 Global Eptacog Alfa (rFVIIa) Revenue by Type (2026-2031)
4.2.3 Global Eptacog Alfa (rFVIIa) Revenue Market Share by Type (2020-2031)
4.3 Global Eptacog Alfa (rFVIIa) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Eptacog Alfa (rFVIIa) Sales by Application (2020-2031)
5.1.1 Global Eptacog Alfa (rFVIIa) Sales by Application (2020-2025)
5.1.2 Global Eptacog Alfa (rFVIIa) Sales by Application (2026-2031)
5.1.3 Global Eptacog Alfa (rFVIIa) Sales Market Share by Application (2020-2031)
5.2 Global Eptacog Alfa (rFVIIa) Revenue by Application (2020-2031)
5.2.1 Global Eptacog Alfa (rFVIIa) Revenue by Application (2020-2025)
5.2.2 Global Eptacog Alfa (rFVIIa) Revenue by Application (2026-2031)
5.2.3 Global Eptacog Alfa (rFVIIa) Revenue Market Share by Application (2020-2031)
5.3 Global Eptacog Alfa (rFVIIa) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Eptacog Alfa (rFVIIa) Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 LFB SA
6.2.1 LFB SA Company Information
6.2.2 LFB SA Description and Business Overview
6.2.3 LFB SA Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 LFB SA Eptacog Alfa (rFVIIa) Product Portfolio
6.2.5 LFB SA Recent Developments/Updates
6.3 GENERIUM
6.3.1 GENERIUM Company Information
6.3.2 GENERIUM Description and Business Overview
6.3.3 GENERIUM Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GENERIUM Eptacog Alfa (rFVIIa) Product Portfolio
6.3.5 GENERIUM Recent Developments/Updates
6.4 Northland-bio
6.4.1 Northland-bio Company Information
6.4.2 Northland-bio Description and Business Overview
6.4.3 Northland-bio Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Northland-bio Eptacog Alfa (rFVIIa) Product Portfolio
6.4.5 Northland-bio Recent Developments/Updates
6.5 CSL
6.5.1 CSL Company Information
6.5.2 CSL Description and Business Overview
6.5.3 CSL Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CSL Eptacog Alfa (rFVIIa) Product Portfolio
6.5.5 CSL Recent Developments/Updates
6.6 Shire (Takeda)
6.6.1 Shire (Takeda) Company Information
6.6.2 Shire (Takeda) Description and Business Overview
6.6.3 Shire (Takeda) Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shire (Takeda) Eptacog Alfa (rFVIIa) Product Portfolio
6.6.5 Shire (Takeda) Recent Developments/Updates
6.7 Bayer
6.7.1 Bayer Company Information
6.7.2 Bayer Description and Business Overview
6.7.3 Bayer Eptacog Alfa (rFVIIa) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bayer Eptacog Alfa (rFVIIa) Product Portfolio
6.7.5 Bayer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eptacog Alfa (rFVIIa) Industry Chain Analysis
7.2 Eptacog Alfa (rFVIIa) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eptacog Alfa (rFVIIa) Production Mode & Process Analysis
7.4 Eptacog Alfa (rFVIIa) Sales and Marketing
7.4.1 Eptacog Alfa (rFVIIa) Sales Channels
7.4.2 Eptacog Alfa (rFVIIa) Distributors
7.5 Eptacog Alfa (rFVIIa) Customer Analysis
8 Eptacog Alfa (rFVIIa) Market Dynamics
8.1 Eptacog Alfa (rFVIIa) Industry Trends
8.2 Eptacog Alfa (rFVIIa) Market Drivers
8.3 Eptacog Alfa (rFVIIa) Market Challenges
8.4 Eptacog Alfa (rFVIIa) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Eptacog Alfa (rFVIIa) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Eptacog Alfa (rFVIIa) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Eptacog Alfa (rFVIIa) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Eptacog Alfa (rFVIIa) Sales (g) of Key Manufacturers (2020-2025)
Table 5. Global Eptacog Alfa (rFVIIa) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Eptacog Alfa (rFVIIa) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Eptacog Alfa (rFVIIa) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Eptacog Alfa (rFVIIa) Average Price (US$/mg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Eptacog Alfa (rFVIIa), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Eptacog Alfa (rFVIIa), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Eptacog Alfa (rFVIIa), Product Type & Application
Table 12. Global Key Manufacturers of Eptacog Alfa (rFVIIa), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Eptacog Alfa (rFVIIa) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eptacog Alfa (rFVIIa) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Eptacog Alfa (rFVIIa) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Eptacog Alfa (rFVIIa) Sales by Region (2020-2025) & (g)
Table 18. Global Eptacog Alfa (rFVIIa) Sales Market Share by Region (2020-2025)
Table 19. Global Eptacog Alfa (rFVIIa) Sales by Region (2026-2031) & (g)
Table 20. Global Eptacog Alfa (rFVIIa) Sales Market Share by Region (2026-2031)
Table 21. Global Eptacog Alfa (rFVIIa) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Region (2020-2025)
Table 23. Global Eptacog Alfa (rFVIIa) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Region (2026-2031)
Table 25. North America Eptacog Alfa (rFVIIa) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Eptacog Alfa (rFVIIa) Sales by Country (2020-2025) & (g)
Table 27. North America Eptacog Alfa (rFVIIa) Sales by Country (2026-2031) & (g)
Table 28. North America Eptacog Alfa (rFVIIa) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Eptacog Alfa (rFVIIa) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Eptacog Alfa (rFVIIa) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Eptacog Alfa (rFVIIa) Sales by Country (2020-2025) & (g)
Table 32. Europe Eptacog Alfa (rFVIIa) Sales by Country (2026-2031) & (g)
Table 33. Europe Eptacog Alfa (rFVIIa) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Eptacog Alfa (rFVIIa) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Eptacog Alfa (rFVIIa) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Eptacog Alfa (rFVIIa) Sales by Region (2020-2025) & (g)
Table 37. Asia Pacific Eptacog Alfa (rFVIIa) Sales by Region (2026-2031) & (g)
Table 38. Asia Pacific Eptacog Alfa (rFVIIa) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Eptacog Alfa (rFVIIa) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Eptacog Alfa (rFVIIa) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Eptacog Alfa (rFVIIa) Sales by Country (2020-2025) & (g)
Table 42. Latin America Eptacog Alfa (rFVIIa) Sales by Country (2026-2031) & (g)
Table 43. Latin America Eptacog Alfa (rFVIIa) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Eptacog Alfa (rFVIIa) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Eptacog Alfa (rFVIIa) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Eptacog Alfa (rFVIIa) Sales by Country (2020-2025) & (g)
Table 47. Middle East and Africa Eptacog Alfa (rFVIIa) Sales by Country (2026-2031) & (g)
Table 48. Middle East and Africa Eptacog Alfa (rFVIIa) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Eptacog Alfa (rFVIIa) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Eptacog Alfa (rFVIIa) Sales (g) by Type (2020-2025)
Table 51. Global Eptacog Alfa (rFVIIa) Sales (g) by Type (2026-2031)
Table 52. Global Eptacog Alfa (rFVIIa) Sales Market Share by Type (2020-2025)
Table 53. Global Eptacog Alfa (rFVIIa) Sales Market Share by Type (2026-2031)
Table 54. Global Eptacog Alfa (rFVIIa) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Eptacog Alfa (rFVIIa) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Type (2020-2025)
Table 57. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Type (2026-2031)
Table 58. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Type (2020-2025)
Table 59. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Type (2026-2031)
Table 60. Global Eptacog Alfa (rFVIIa) Sales (g) by Application (2020-2025)
Table 61. Global Eptacog Alfa (rFVIIa) Sales (g) by Application (2026-2031)
Table 62. Global Eptacog Alfa (rFVIIa) Sales Market Share by Application (2020-2025)
Table 63. Global Eptacog Alfa (rFVIIa) Sales Market Share by Application (2026-2031)
Table 64. Global Eptacog Alfa (rFVIIa) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Eptacog Alfa (rFVIIa) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Application (2020-2025)
Table 67. Global Eptacog Alfa (rFVIIa) Revenue Market Share by Application (2026-2031)
Table 68. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Application (2020-2025)
Table 69. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Application (2026-2031)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 73. Novo Nordisk Eptacog Alfa (rFVIIa) Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. LFB SA Company Information
Table 76. LFB SA Description and Business Overview
Table 77. LFB SA Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 78. LFB SA Eptacog Alfa (rFVIIa) Product
Table 79. LFB SA Recent Developments/Updates
Table 80. GENERIUM Company Information
Table 81. GENERIUM Description and Business Overview
Table 82. GENERIUM Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 83. GENERIUM Eptacog Alfa (rFVIIa) Product
Table 84. GENERIUM Recent Developments/Updates
Table 85. Northland-bio Company Information
Table 86. Northland-bio Description and Business Overview
Table 87. Northland-bio Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 88. Northland-bio Eptacog Alfa (rFVIIa) Product
Table 89. Northland-bio Recent Developments/Updates
Table 90. CSL Company Information
Table 91. CSL Description and Business Overview
Table 92. CSL Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 93. CSL Eptacog Alfa (rFVIIa) Product
Table 94. CSL Recent Developments/Updates
Table 95. Shire (Takeda) Company Information
Table 96. Shire (Takeda) Description and Business Overview
Table 97. Shire (Takeda) Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 98. Shire (Takeda) Eptacog Alfa (rFVIIa) Product
Table 99. Shire (Takeda) Recent Developments/Updates
Table 100. Bayer Company Information
Table 101. Bayer Description and Business Overview
Table 102. Bayer Eptacog Alfa (rFVIIa) Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 103. Bayer Eptacog Alfa (rFVIIa) Product
Table 104. Bayer Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Eptacog Alfa (rFVIIa) Distributors List
Table 108. Eptacog Alfa (rFVIIa) Customers List
Table 109. Eptacog Alfa (rFVIIa) Market Trends
Table 110. Eptacog Alfa (rFVIIa) Market Drivers
Table 111. Eptacog Alfa (rFVIIa) Market Challenges
Table 112. Eptacog Alfa (rFVIIa) Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Eptacog Alfa (rFVIIa)
Figure 2. Global Eptacog Alfa (rFVIIa) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Eptacog Alfa (rFVIIa) Market Share by Type: 2024 & 2031
Figure 4. Freeze-dried Preparation Product Picture
Figure 5. Freeze-dried Powder Product Picture
Figure 6. Global Eptacog Alfa (rFVIIa) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Eptacog Alfa (rFVIIa) Market Share by Application: 2024 & 2031
Figure 8. Hemophilia
Figure 9. Acquired Hemophilia
Figure 10. Factor VII Deficiency
Figure 11. Glanzmann Thrombasthenia (GT)
Figure 12. Global Eptacog Alfa (rFVIIa) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Eptacog Alfa (rFVIIa) Market Size (2020-2031) & (US$ Million)
Figure 14. Global Eptacog Alfa (rFVIIa) Sales (2020-2031) & (g)
Figure 15. Global Eptacog Alfa (rFVIIa) Average Price (US$/mg) & (2020-2031)
Figure 16. Eptacog Alfa (rFVIIa) Report Years Considered
Figure 17. Eptacog Alfa (rFVIIa) Sales Share by Manufacturers in 2024
Figure 18. Global Eptacog Alfa (rFVIIa) Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Eptacog Alfa (rFVIIa) Players: Market Share by Revenue in Eptacog Alfa (rFVIIa) in 2024
Figure 20. Eptacog Alfa (rFVIIa) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Eptacog Alfa (rFVIIa) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Eptacog Alfa (rFVIIa) Sales Market Share by Country (2020-2031)
Figure 23. North America Eptacog Alfa (rFVIIa) Revenue Market Share by Country (2020-2031)
Figure 24. United States Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Eptacog Alfa (rFVIIa) Sales Market Share by Country (2020-2031)
Figure 27. Europe Eptacog Alfa (rFVIIa) Revenue Market Share by Country (2020-2031)
Figure 28. Germany Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Eptacog Alfa (rFVIIa) Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Eptacog Alfa (rFVIIa) Revenue Market Share by Region (2020-2031)
Figure 35. China Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Eptacog Alfa (rFVIIa) Sales Market Share by Country (2020-2031)
Figure 45. Latin America Eptacog Alfa (rFVIIa) Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Eptacog Alfa (rFVIIa) Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Eptacog Alfa (rFVIIa) Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Eptacog Alfa (rFVIIa) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Eptacog Alfa (rFVIIa) by Type (2020-2031)
Figure 55. Global Revenue Market Share of Eptacog Alfa (rFVIIa) by Type (2020-2031)
Figure 56. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Type (2020-2031)
Figure 57. Global Sales Market Share of Eptacog Alfa (rFVIIa) by Application (2020-2031)
Figure 58. Global Revenue Market Share of Eptacog Alfa (rFVIIa) by Application (2020-2031)
Figure 59. Global Eptacog Alfa (rFVIIa) Price (US$/mg) by Application (2020-2031)
Figure 60. Eptacog Alfa (rFVIIa) Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
